Trial Details

COMPLETED
Basic Information
Clinical ID c2878
Identifier NCT02847884
Trial Title IDeaL Pilot Study - Infliximab Dose to Level: Pilot Study
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Bowel Disease|Crohn's Disease
Interventions BIOLOGICAL: Infliximab
Participant Information
Sponsor University of Alberta
City Alberta
Country/Region Canada
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2015-10
Primary Completion Date 2017-12
Completion Date 2018-06